Suppr超能文献

通过聚合牛去基质溶血产物制备的含有过氧化氢酶和超氧化物歧化酶活性的去基质多溶血产物的免疫学特性。

The immunological properties of stroma-free polyhemolysate containing catalase and superoxide dismutase activities prepared by polymerized bovine stroma-free hemolysate.

作者信息

Zhu Hongli, Du Qianqian, Chen Chao, Chang Thomas Ming Swi

机构信息

National Engineering Research Center for Miniaturized Detection Systems, College of Life Science, Northwest University, Xi'an, Shaanxi, China.

出版信息

Artif Cells Blood Substit Immobil Biotechnol. 2010 Apr;38(2):57-63. doi: 10.3109/10731191003634232.

Abstract

Crosslinking of ultrapure hemoglobin, crystalline catalase, and superoxide dismutase resulted in a soluble nanodimensional complex of polyhemoglobin-catalase-superoxide dismutase. A less expensive and more convenient way is to crosslink bovine stroma-free hemolysate (stroma-free hemolysate) that already contains hemoglobin, catalase, and superoxide dismutase into polyhemoglobin with catalase and superoxide dismutase activities (stroma-free polyhemolysate) [21]. The objective of the present study is to evaluate the immunological properties of this stroma-free polyhemolysate. Each of three groups of rats received weekly subcutaneous injections of one of the stroma-free polyhemolysate, stroma-free hemolysate, and saline for four weeks. One week after the four cycles of weekly immunization, serum and plasma were collected for C3a complement activation tests and Ouchterlony antibody-antigen precipitation tests, respectively. Results show that stroma-free polyhemolysate retained significant antioxidant enzyme activity. The C3a complement activation test and Ouchterlony test show that four weekly subcutaneous injections of bovine stroma-free polyhemolysate did not result in any immunological reaction in rats when tested this way.

摘要

超纯血红蛋白、结晶过氧化氢酶和超氧化物歧化酶交联后形成了一种可溶性的聚血红蛋白-过氧化氢酶-超氧化物歧化酶纳米复合物。一种成本更低且更便捷的方法是将已含有血红蛋白、过氧化氢酶和超氧化物歧化酶的牛去基质溶血产物(去基质溶血产物)交联成具有过氧化氢酶和超氧化物歧化酶活性的聚血红蛋白(去基质聚溶血产物)[21]。本研究的目的是评估这种去基质聚溶血产物的免疫学特性。三组大鼠每组每周皮下注射一次去基质聚溶血产物、去基质溶血产物和生理盐水,共注射四周。在每周免疫四个周期后的一周,分别采集血清和血浆用于C3a补体激活试验和双向免疫扩散抗体-抗原沉淀试验。结果表明,去基质聚溶血产物保留了显著的抗氧化酶活性。C3a补体激活试验和双向免疫扩散试验表明,以这种方式测试时,每周皮下注射四次牛去基质聚溶血产物不会在大鼠中引发任何免疫反应。

相似文献

5
Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase.
Artif Cells Blood Substit Immobil Biotechnol. 2009;37(2):69-77. doi: 10.1080/10731190902742240. Epub 2009 Feb 18.
9
Two future generations of blood substitutes based on polyhemoglobin-SOD-catalase and nanoencapsulation.
Adv Drug Deliv Rev. 2000 Feb 28;40(3):213-8. doi: 10.1016/s0169-409x(99)00051-4.
10
Immunological effects of hemoglobin, encapsulated hemoglobin, polyhemoglobin and conjugated hemoglobin using different immunization schedules.
Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):611-8. doi: 10.3109/10731199209119690.

本文引用的文献

2
Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase.
Artif Cells Blood Substit Immobil Biotechnol. 2009;37(2):69-77. doi: 10.1080/10731190902742240. Epub 2009 Feb 18.
3
Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial.
J Am Coll Surg. 2009 Jan;208(1):1-13. doi: 10.1016/j.jamcollsurg.2008.09.023. Epub 2008 Nov 7.
6
Perborate as substrate in a new assay of catalase.
J Biol Chem. 1949 Oct;180(3):1197-1202.
8
First-generation blood substitutes: what have we learned? Biochemical and physiological perspectives.
Expert Opin Biol Ther. 2007 May;7(5):665-75. doi: 10.1517/14712598.7.5.665.
9
Blood substitutes based on nanobiotechnology.
Trends Biotechnol. 2006 Aug;24(8):372-7. doi: 10.1016/j.tibtech.2006.06.005. Epub 2006 Jul 11.
10
Therapeutic applications of polymeric artificial cells.
Nat Rev Drug Discov. 2005 Mar;4(3):221-35. doi: 10.1038/nrd1659.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验